Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Ophthalmic

Retinitis Pigmentosa 33

Assembled from catalogue records November 18, 2026

Retinitis Pigmentosa 33, as genome-wide studies have reported it: 5 positions from 1 study. Assembled by code from the GWAS Catalog's records and kept current as positions arrive; every figure is the studies' own.

What this condition connects to

Prevalence
Not taken from these records, which report study sizes rather than how common the condition is.
Inheritance
Many positions, each with a small effect: 5 positions across 1 study, the pattern of a polygenic condition. The records do not give a heritability, and this page does not supply one.

1 study in the GWAS Catalog report 5 positions for Retinitis Pigmentosa 33, which the catalogue files as "Retinitis pigmentosa 33". MyGeneLog follows the condition as positions arrive: code builds this page from the records, adds each new position when it is reported, and writes no sentence of its own beyond them.

Where the positions come from

A study. It contributes 5 positions: rs1470798497 (SNRNP200), rs2063883437 (SNRNP200), rs267607077 (SNRNP200), rs397514574 (SNRNP200), rs397514575 (SNRNP200).

Where they lie in the genome

The catalogue maps the 5 positions to 1 gene: SNRNP200. That mapping says where a position sits, in a gene or beside one — not what it does. For what each study measured, follow its citation above.

What these records can and cannot tell you

Read this page as a list of findings about Retinitis Pigmentosa 33, not as an account of it. Each finding is a position that a genome-wide study linked to the condition across a population; the page adds no description, no prevalence and no advice, because the records hold none. The variant pages linked above give each study's record for its position, and ClinVar's where one exists.

Clinical detail

What is actually diagnosed and treated here

A genotype does not diagnose Retinitis Pigmentosa 33; a clinician does. No guideline uses the 5 variants on this page to predict it, screen for it or confirm it.

Its sources are association records, and association records carry no clinical guidance, so neither does this page. What a genome-wide study reports is a difference between groups of people, not a finding about any one person. Symptoms, tests and treatment are questions for a clinician.

Sources

Databases, guidelines and references

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Retinitis Pigmentosa 33. MyGeneLog™. https://www.mygenelog.com/conditions/retinitis-pigmentosa-33

Questions about Retinitis Pigmentosa 33

What is Retinitis Pigmentosa 33?

Retinitis Pigmentosa 33 is the condition the GWAS Catalog files under "Retinitis pigmentosa 33". This page does not define it in its own words; it lists what genome-wide studies have reported: 5 positions from 1 study, with each study's sample and citation.

Is Retinitis Pigmentosa 33 genetic?

Genes play a part: 5 positions have been linked to it. But each is a common variant of small effect, and a link found across a population does not cause the condition in any one person.

Which genes are linked to Retinitis Pigmentosa 33 on this page?

The catalogue maps the positions to 1 gene: SNRNP200. These are where the positions sit, not proof of how they act.

Can these variants predict whether I will get Retinitis Pigmentosa 33?

No. They are population-level findings of small effect. Retinitis Pigmentosa 33 is diagnosed by a clinician, and no guideline uses a genotype to predict it.

Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.